Ophthalmology PACS Market Size to Hit USD 333.32 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ophthalmology PACS Market

5.1. COVID-19 Landscape: Ophthalmology PACS Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ophthalmology PACS Market, By Component

8.1. Ophthalmology PACS Market Revenue and Volume, by Component

8.1.1. Software

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Services

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Hardware

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Ophthalmology PACS Market, By Deployment Mode

9.1. Ophthalmology PACS Market Revenue and Volume, by Deployment Mode

9.1.1. On-Premises

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cloud-Based

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Hybrid

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Ophthalmology PACS Market, By End User

10.1. Ophthalmology PACS Market Revenue and Volume, by End User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Specialty Eye Clinics & Ambulatory Surgical Centers (ASCs)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Diagnostic Imaging Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Academic & Research Institutes

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Ophthalmology PACS Market, By Imaging Modality

11.1. Ophthalmology PACS Market Revenue and Volume, by Imaging Modality

11.1.1. Optical Coherence Tomography (OCT)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Fundus Photography

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Fluorescein Angiography

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Ultrasound

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Visual Field Testing

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others (Slit Lamp Imaging, Corneal Topography, etc.)

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Ophthalmology PACS Market, By Functionality

12.1. Ophthalmology PACS Market Revenue and Volume, by Functionality

12.1.1. Image Storage & Retrieval

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Workflow Management

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Image Sharing / Distribution

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. EHR/EMR Integration

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Analytics & Reporting

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Ophthalmology PACS Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Component

13.1.2. Market Revenue and Volume Forecast, by Deployment Mode

13.1.3. Market Revenue and Volume Forecast, by End User

13.1.4. Market Revenue and Volume Forecast, by Imaging Modality

13.1.5. Market Revenue and Volume Forecast, by Functionality

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Component

13.1.6.2. Market Revenue and Volume Forecast, by Deployment Mode

13.1.6.3. Market Revenue and Volume Forecast, by End User

13.1.6.4. Market Revenue and Volume Forecast, by Imaging Modality

13.1.6.5. Market Revenue and Volume Forecast, by Functionality

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Component

13.1.7.2. Market Revenue and Volume Forecast, by Deployment Mode

13.1.7.3. Market Revenue and Volume Forecast, by End User

13.1.7.4. Market Revenue and Volume Forecast, by Imaging Modality

13.1.7.5. Market Revenue and Volume Forecast, by Functionality

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Component

13.2.2. Market Revenue and Volume Forecast, by Deployment Mode

13.2.3. Market Revenue and Volume Forecast, by End User

13.2.4. Market Revenue and Volume Forecast, by Imaging Modality

13.2.5. Market Revenue and Volume Forecast, by Functionality

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Component

13.2.6.2. Market Revenue and Volume Forecast, by Deployment Mode

13.2.6.3. Market Revenue and Volume Forecast, by End User

13.2.7. Market Revenue and Volume Forecast, by Imaging Modality

13.2.8. Market Revenue and Volume Forecast, by Functionality

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Component

13.2.9.2. Market Revenue and Volume Forecast, by Deployment Mode

13.2.9.3. Market Revenue and Volume Forecast, by End User

13.2.10. Market Revenue and Volume Forecast, by Imaging Modality

13.2.11. Market Revenue and Volume Forecast, by Functionality

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Component

13.2.12.2. Market Revenue and Volume Forecast, by Deployment Mode

13.2.12.3. Market Revenue and Volume Forecast, by End User

13.2.12.4. Market Revenue and Volume Forecast, by Imaging Modality

13.2.13. Market Revenue and Volume Forecast, by Functionality

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Component

13.2.14.2. Market Revenue and Volume Forecast, by Deployment Mode

13.2.14.3. Market Revenue and Volume Forecast, by End User

13.2.14.4. Market Revenue and Volume Forecast, by Imaging Modality

13.2.15. Market Revenue and Volume Forecast, by Functionality

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Component

13.3.2. Market Revenue and Volume Forecast, by Deployment Mode

13.3.3. Market Revenue and Volume Forecast, by End User

13.3.4. Market Revenue and Volume Forecast, by Imaging Modality

13.3.5. Market Revenue and Volume Forecast, by Functionality

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Component

13.3.6.2. Market Revenue and Volume Forecast, by Deployment Mode

13.3.6.3. Market Revenue and Volume Forecast, by End User

13.3.6.4. Market Revenue and Volume Forecast, by Imaging Modality

13.3.7. Market Revenue and Volume Forecast, by Functionality

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Component

13.3.8.2. Market Revenue and Volume Forecast, by Deployment Mode

13.3.8.3. Market Revenue and Volume Forecast, by End User

13.3.8.4. Market Revenue and Volume Forecast, by Imaging Modality

13.3.9. Market Revenue and Volume Forecast, by Functionality

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Component

13.3.10.2. Market Revenue and Volume Forecast, by Deployment Mode

13.3.10.3. Market Revenue and Volume Forecast, by End User

13.3.10.4. Market Revenue and Volume Forecast, by Imaging Modality

13.3.10.5. Market Revenue and Volume Forecast, by Functionality

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Component

13.3.11.2. Market Revenue and Volume Forecast, by Deployment Mode

13.3.11.3. Market Revenue and Volume Forecast, by End User

13.3.11.4. Market Revenue and Volume Forecast, by Imaging Modality

13.3.11.5. Market Revenue and Volume Forecast, by Functionality

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Component

13.4.2. Market Revenue and Volume Forecast, by Deployment Mode

13.4.3. Market Revenue and Volume Forecast, by End User

13.4.4. Market Revenue and Volume Forecast, by Imaging Modality

13.4.5. Market Revenue and Volume Forecast, by Functionality

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Component

13.4.6.2. Market Revenue and Volume Forecast, by Deployment Mode

13.4.6.3. Market Revenue and Volume Forecast, by End User

13.4.6.4. Market Revenue and Volume Forecast, by Imaging Modality

13.4.7. Market Revenue and Volume Forecast, by Functionality

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Component

13.4.8.2. Market Revenue and Volume Forecast, by Deployment Mode

13.4.8.3. Market Revenue and Volume Forecast, by End User

13.4.8.4. Market Revenue and Volume Forecast, by Imaging Modality

13.4.9. Market Revenue and Volume Forecast, by Functionality

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Component

13.4.10.2. Market Revenue and Volume Forecast, by Deployment Mode

13.4.10.3. Market Revenue and Volume Forecast, by End User

13.4.10.4. Market Revenue and Volume Forecast, by Imaging Modality

13.4.10.5. Market Revenue and Volume Forecast, by Functionality

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Component

13.4.11.2. Market Revenue and Volume Forecast, by Deployment Mode

13.4.11.3. Market Revenue and Volume Forecast, by End User

13.4.11.4. Market Revenue and Volume Forecast, by Imaging Modality

13.4.11.5. Market Revenue and Volume Forecast, by Functionality

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Component

13.5.2. Market Revenue and Volume Forecast, by Deployment Mode

13.5.3. Market Revenue and Volume Forecast, by End User

13.5.4. Market Revenue and Volume Forecast, by Imaging Modality

13.5.5. Market Revenue and Volume Forecast, by Functionality

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Component

13.5.6.2. Market Revenue and Volume Forecast, by Deployment Mode

13.5.6.3. Market Revenue and Volume Forecast, by End User

13.5.6.4. Market Revenue and Volume Forecast, by Imaging Modality

13.5.7. Market Revenue and Volume Forecast, by Functionality

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Component

13.5.8.2. Market Revenue and Volume Forecast, by Deployment Mode

13.5.8.3. Market Revenue and Volume Forecast, by End User

13.5.8.4. Market Revenue and Volume Forecast, by Imaging Modality

13.5.8.5. Market Revenue and Volume Forecast, by Functionality

Chapter 14. Company Profiles

14.1. Carl Zeiss Meditec AG

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Topcon Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Abbott

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Heidelberg Engineering GmbH

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sonomed Escalon

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Visbion Ltd

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. IBM Watson Health (Merge PACS)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. EyePACS, LLC

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Agfa-Gevaert Group

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Canon Medical Systems Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global ophthalmology PACS market size is expected to increase from USD 163.84 million in 2024 to USD 333.32 million by 2034.

The ophthalmology PACS market is anticipated to grow at a CAGR of 7.36% between 2025 and 2034.

The major players in the ophthalmology PACS market include Carl Zeiss Meditec AG, Topcon Corporation, Heidelberg Engineering GmbH, Sonomed Escalon, Visbion Ltd, IBM Watson Health (Merge PACS), EyePACS, LLC, Agfa-Gevaert Group, Canon Medical Systems Corporation, Siemens Healthineers, Carestream Health, Merge Healthcare Inc., Medisoft Limited, NIDEK Co., Ltd., NextGen Healthcare, ScImage Inc., EyeMD EMR Healthcare Systems, Inc., Intelligent Retinal Imaging Systems (IRIS), and Kowa Company, Ltd., MedWeb.

The driving factors of the ophthalmology PACS market are the increased prevalence of eye diseases, emerging technology, digital healthcare, aging populations, and the smooth integration of EHRs.

North America region will lead the global ophthalmology PACS market during the forecast period 2025 to 2034.